Gene Test Improves Coumadin (Warfarin) Use for Stroke Prevention in Atrial Fibrillation (AF)
Genetic tests that show high or low sensitivity to blood thinner (anticoagulant) drugs like warfarin (Coumadin) not only improve dosing accuracy but also reduce hospitalization by 31 percent, according to a new study just presented at the American College of Cardiology scientific sessions. Coumadin is often prescribed for people who have afib to prevent blood clots that can cause strokes.
Read more: Gene Test Improves Use of Coumadin (warfarin) for Stroke Prevention in Atrial Fibrillation
We value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.
Add a CommentComments
There are no comments yet. Be the first one and get the conversation started!